Lexeo Therapeutics (NASDAQ:LXEO) is one of billionaire Daniel Sundheim’s stock picks with huge upside potential. On October 21, Leerink’s Mani Foroohar lowered the price target on Lexeo Therapeutics (NASDAQ:LXEO) from $20 to$18 but maintained an Outperform rating. Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim's Stock Picks with Huge Upside Potential Likoper/Shutterstock.com The revision followed Lexeo’s $135 million capital raise through a secondary offering and private placement, alon ...